Bacampicillin
Bacampicillin (INN) is a penicillin antibiotic. It serves as a prodrug designed to improve the oral bioavailability of ampicillin.
History and Development
Bacampicillin was developed to enhance the absorption of ampicillin in the body. As a prodrug, bacampicillin is metabolized in the body to produce ampicillin, thereby allowing for greater concentrations of the antibiotic in the bloodstream when taken orally.
Brand Names and Availability
Bacampicillin is marketed under the following brand names:
- Spectrobid – Manufactured by Pfizer
- Penglobe – Produced by AstraZeneca
Despite its usage in various regions, bacampicillin is not available in the United States.
Mechanism of Action
Like ampicillin, bacampicillin functions by inhibiting the synthesis of the bacterial cell wall, leading to the death of susceptible bacteria. The primary advantage of bacampicillin over ampicillin is its improved bioavailability when taken orally, ensuring more consistent therapeutic levels in the body.
Indications
Bacampicillin is prescribed for the treatment of various bacterial infections, especially those caused by penicillin-sensitive organisms. Its efficacy and indications largely align with those of ampicillin due to its conversion to ampicillin in vivo.
Side Effects and Precautions
Patients using bacampicillin may experience side effects common to penicillin antibiotics, such as gastrointestinal disturbances, allergic reactions, and skin rashes. It is essential to avoid use in patients with known penicillin allergies.
References
- Johnson, L.R. (2015). Antibiotics and Their Applications. Oxford University Press.
- Smith, A. & Green, B. (2013). Modern Developments in Antibacterial Therapy. Elsevier.
Penicillin antibiotics
- penicillins first generation (natural penicillins)
- penicillins second generation (penicillinase-resistant penicillins)
- penicillins third generation (aminopenicillins)
- see also amoxicillin-clavulanate
- penicillins fourth generation (extended-spectrum penicillins)
Transform your life with W8MD's budget GLP-1 injections from $125.
W8MD offers a medical weight loss program to lose weight in Philadelphia. Our physician-supervised medical weight loss provides:
- Most insurances accepted or discounted self-pay rates. We will obtain insurance prior authorizations if needed.
- Generic GLP1 weight loss injections from $125 for the starting dose.
- Also offer prescription weight loss medications including Phentermine, Qsymia, Diethylpropion, Contrave etc.
NYC weight loss doctor appointments
Start your NYC weight loss journey today at our NYC medical weight loss and Philadelphia medical weight loss clinics.
- Call 718-946-5500 to lose weight in NYC or for medical weight loss in Philadelphia 215-676-2334.
- Tags:NYC medical weight loss, Philadelphia lose weight Zepbound NYC, Budget GLP1 weight loss injections, Wegovy Philadelphia, Wegovy NYC, Philadelphia medical weight loss, Brookly weight loss and Wegovy NYC
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD